Product · #14 of 27 · multi-symptom (single active)

Estroven Complete Menopause Relief Gummies

Gummy from Estroven, made by i-Health (dsm-firmenich). Daily serving: 1 gummy (10 kcal, 1 g added sugar).

Last updated · Price and ratings checked Nov 19, 2026

In short: Estroven Complete Menopause Relief Gummies scores 50.3/100 in our ranking (#14 of 27). It costs $0.88 a day at the regular price. Evidence: ERr 731 4 mg; no product trial; best ingredient grade C (ERr 731 rhapontic rhubarb). No NSF registry listing was confirmed.

Pros

  • Evidence: ERr 731 4 mg; no product trial.

Cons

  • No NSF registry listing confirmed.
  • Legal or regulatory history: see flags below.

Flags

Class actionWatchdog complaint

Score breakdown

Evidence
27/40
NSF-verified testing
4/20
Value ($/day)
13.5/20
Ingredients
2/10
Amazon rating
3.8/10

How we score

Full label: what's in it

Supplement Facts actives per daily serving (1 gummy (10 kcal, 1 g added sugar)). Source: label or official page, checked Nov 19, 2026.
Ingredient (as labeled)Per dayEvidence page
Rhapontic rhubarb root extract ERr 7314 mgERr 731 rhapontic rhubarb C

Evidence

Our evidence score: 27/40, because: ERr 731 4 mg; no product trial.

Product-level research: we found no published trial of this exact product, so its evidence comes from studies of its ingredients.

Ingredient evidence

  • ERr 731 rhapontic rhubarb C (4 mg here)
    ERr 731 is a rhapontic rhubarb root extract (the active in Estroven Complete) studied in perimenopausal women for occasional hot flashes and related symptoms*. The placebo-controlled trials come from one research group. The Menopause Society 2023: Not recommended (Level II) – placebo-arm retention only 12.7% in key RCT; open-label study.

Studies

Studies on its ingredients (4)
  • Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12-week randomized, double-blind, placebo-controlled trial.

    Heger M, Ventskovskiy BM, Borzenko I et al. · Menopause 2006 · ERr 731 rhapontic rhubarb

    109 perimenopausal women took the rhubarb-root extract ERr 731 (sold as Estrovera/Estroven Complete) or placebo for 12 weeks. Symptoms including hot flashes improved strongly. However, most women on placebo dropped out, which makes the comparison less reliable.

    Who
    109 perimenopausal women
    Dose
    ERr 731 one tablet/day (4 mg)
    Duration
    12 weeks
    Result
    MRS total and each symptom improved vs placebo (P<.0001); fewer and milder hot flushes from week 4; no endometrial changes. NAMS notes only 7/55 placebo completers.
    Funding
    Authors from Health Research Services Ltd; manufacturer (Dr. Loges) funding not stated in abstract. Industry-linked

    PubMed · Full text (DOI)

  • Confirmation of the efficacy of ERr 731 in perimenopausal women with menopausal symptoms.

    Kaszkin-Bettag M, Ventskovskiy BM, Solskyy S et al. · Altern Ther Health Med 2009 · ERr 731 rhapontic rhubarb

    A second 12-week trial by the same research group (112 women) again found large improvements with ERr 731 versus placebo. Independent replication is still lacking.

    Who
    112 perimenopausal women
    Dose
    ERr 731 one tablet/day
    Duration
    12 weeks
    Result
    MRS total 27.0→12.4 vs 27.0→24.0 placebo (P<.0001); hot flushes reduced.
    Funding
    Same research group as the original trial; funding not stated in abstract. Industry-linked

    PubMed

  • Efficacy evaluation of standardized Rheum rhaponticum root extract (ERr 731 (®)) on symptoms of menopause: A systematic review and meta-analysis study.

    Dubey VP, Sureja VP, Kheni DB · J Biomed Res 2024 · ERr 731 rhapontic rhubarb

    A pooled analysis of 4 ERr 731 studies found large symptom reductions, but the analysis was written by staff of a company that sells the extract.

    Who
    4 studies, 390 women
    Dose
    ERr 731
    Duration
    12 weeks
    Result
    Pooled MRS reduction -15.1 points vs control (P<.001).
    Funding
    Lead authors from Sundyota Numandis (Indian distributor) – industry-affiliated. Industry-linked

    PubMed · Full text (DOI)

  • Association between Extract Rheum rhaponticum 731 (ERr 731) prescription and subsequent breast cancer.

    Heger PW, Hotz D, Kalder M et al. · Breast Cancer Res Treat 2025 · ERr 731 rhapontic rhubarb

    In German medical records, women prescribed ERr 731 were not more likely to be diagnosed with breast cancer than women who were not. This is observational, partly industry-linked data.

    Who
    5,686 users vs 17,058 non-users (German records)
    Dose
    ERr 731 prescriptions
    Duration
    observational
    Result
    No increase in breast-cancer diagnosis (OR 1.01, 95% CI 0.81–1.26).
    Funding
    Two authors employed by Health Research Services GmbH. Industry-linked

    PubMed · Full text (DOI)

The Menopause Society's 2023 statement is in the study library.

Price

Regular one-time price$26.48 (30 units, 30 days at label dose)
Cost per day$0.88
SubscriptionAmazon S&S $18.99
Price notesBrand $26.48; Amazon B0GS41K1XH list $24.99 (BF $19.99)
In stock when checkedYes
CheckedNov 19, 2026

Ratings

Amazon: ★ 4.3 from 232 ratings on Amazon (checked Nov 19, 2026)

Star ratings reflect buyer satisfaction, not clinical effect.

Certifications and claims

Verified in a public registry

  • No registry listing found.

Claims made by the brand

  • “hormone-free” Brand claim
  • “drug-free” Brand claim
  • “soy-free (Complete line only)” Brand claim
  • “gluten-free” Brand claim
  • “vegan-suitable (caplet)” Brand claim

Registry check: NSF/ANSI 173 (searched 'Estroven', 'i-Health'): not found

Who's behind it

BrandEstroven
Owner / companyi-Health, Inc. (Cromwell, CT), part of the dsm-firmenich group (estroven.com footer '© 2026 dsm-firmenich group').
FoundersNot stated on the pages we read.
Where it's madeOlder label: 'Made in the USA with US and imported materials' (Weight Management SFP); not stated for others.
Medical advisors named
  • Shavon Jackson-Michel, ND (chair; i-Health Global Scientific Engagement Leader)
  • Alexandra Dubinskaya, MD, FACOG, NCMP
  • Christina Kramer, MD, FACOG, NCMP
  • Komkwuan Paruchabutr, DNP, FNP, WHNP, CNM
  • Kerry-Anne Perkins, DO, FACOG
Sourceestroven.com

Flags & safety

Legal, regulatory and quality flags

  • Class action Arnold v. I-Health, Inc. (C.D. Cal. 2:26-cv-01282, filed 2026) alleges Estroven Mood Boost and Stress Relief claims are false/misleading (not the Complete SKU). classaction.org
  • TINA.org warning letter to i-Health re menopause marketing (Oct 2024). truthinadvertising.org

Ingredient safety notes

  • ERr 731 rhapontic rhubarb: Post-marketing (Germany, ~140M daily doses): mainly hypersensitivity and GI complaints. Observational German data: no increase in breast-cancer diagnosis (OR 1.01, industry-linked). Endometrium unchanged in trials. Contains ER-β–active compounds.

Sources

Talk to a clinician first

The Menopause Society's 2023 nonhormone position statement does not recommend any dietary supplement or herbal remedy for hot flashes, because the research is limited or mixed. Hormone therapy is an option for many women, and the statement lists non-hormonal options with evidence behind them: CBT, clinical hypnosis, SSRIs/SNRIs, gabapentin, fezolinetant (Level I), oxybutynin (I–II), weight loss, stellate ganglion block (II–III).

If hot flashes, night sweats, sleep or mood are affecting your life, talk to a clinician first. If you still want to try a supplement, the rankings below show what is actually in each one, what the research found, and who is behind it. Sources: position statement (PDF) · PubMed.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.